While announcing Q4 and year-ended FY23 earnings report on Wednesday, JB Chemicals & Pharmaceuticals also declared a final dividend and stock split. The pharma player will pay a final dividend of 9.25 per equity share for FY23, while it will also sub-divided its shares in the ratio of 1:2. Dividend:In a meeting held on May 24th, JB Chemicals board of directors recommended a final dividend of 9.25 per equity share having a face value of 2 each for fiscal year FY23. If the said dividend approved in the ensuing annual general meeting, JB plans to pay the benefit to shareholders on or after 10 days from date of AGM. At the current market price, JB’s annualised dividend yield is at 0.65%. Read here: Earlier, in the fiscal, JB paid a dividend of 8.50 per shares for which the stock turned ex-date in February 2023. In FY22, the company paid a dividend of 825% aggregating to 16.5 apiece. Stock split:In the ratio of 1:2, JB Chemical’s existing shares having a face value of 2 each will be sub-dividend into equity shares having a face value of Re 1 each. The reason behind the stock split is to enhance the liquidity of Company’s shares in stock market, to make it more affordable and to broad base shareholding by small investors. Read here: JB expects approximately two months from the date of receipt of shareholders’ approval — for stock split. On BSE, JB Chemicals share price closed at 1919.40 apiece down by 1.59%. In a year, the stock has rallied nearly 23% on this exchange. In Q4FY23, PAT jumped 3.5% to 88 crore as against 85 crore in Q4FY22. Revenue stood at 762 crore, up by 22% from 625 crore in Q4FY22. EBITDA zoomed by 21% to 181 crore in Q4 of FY23, compared to 149 crore in Q4 of the previous fiscal. For the full year FY23, the company recorded revenue of 3,149 crore as compared to 2,424 crore, registering a growth of 30%. Operating EBITDA registered a growth of 26% to 765 crore as compared to 605 crore. Profit after Tax was 410 crore as compared to 386 crore recording growth of 6%.